Investment Information

With transparent disclosure of information and communication with markets,
we will grow along with shareholders.

Corporate Governance Structure

Company Overview

Company Overview
Type Announcement
Representative Seung-kook Park, Seung-won Jeong
Established on November 20th 1973
Listed on December 18th 1989 (listed on KOSPI)
Largest Shareholder Daewoong Pharmaceutical Co., Ltd.
Capital 26.1 billion KRW
Nominal Value 500 KRW
Total Issued shares 52,240,638
Number of Employees 309 (As of Dec.31, 2020)
Board of Directors
Name Background
Jae-chun Yoon Chariman, Board of Directors; Chief Executive Officer, Daewoong Pharmaceutical
Seung-kook Park, Ph.D. President & Chief Executive Officer; Former Head of R&D, Daewoong Pharmaceutical
Sean (Seungwon) Jeong, M.D., MBA President & Chief Executive Officer; Former Head of Bone Japan/China, UCB; Former New Products Director, Novartis
Sung-yon Lim Chief Financial Officer
Jin-hyeong Kim Independent Director; Accountant, Samdo Accounting Firm Partner+K37
Jung-kue Lee Independent Director; Founder & Chief Executive Officer, Bridge Biotherapeutics
Hun Jung, M.D., Ph.D. Independent Director; Founder & Chief Executive Officer, Aston Science